The product is used as a source of water, electrolytes and calories or as an alkalizing agent. The affected lot was distributed between June 2011 and January 2012 to wholesalers/distributors, hospitals and pharmacies.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
While Hospira has not received reports of any adverse events associated with the lot, thrombosis, phlebitis, bacteremia, sepsis, septic shock and/or endocarditis or a fatal infection may result from using contaminated solution on a patient, according to the news release.
Hospira instructs anyone with the lot to stop use and distribution, quarantine the product and call Stericycle to return the product.
More Articles on Patient Safety:
Survey: 11% of Pharmacists Reported Contamination of High-Risk Compounded Sterile Products in Past Year
Patient Safety Tool: Cultural Competence Self-Assessment
Study: Hospitalists’ Unsafe Patient Loads Lead to Poorer Quality Care
